Medicover Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Medicover ha aumentado sus beneficios a una tasa media anual de 0.5%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 31.5% anual. Los ingresos han ido creciendo a una tasa media de 18.5% al año. La rentabilidad financiera de Medicover es de 4.2%, y sus márgenes netos son de 1.2%.

Información clave

0.5%

Tasa de crecimiento de los beneficios

-1.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.1%
Tasa de crecimiento de los ingresos	18.5%
Rentabilidad financiera	4.2%
Margen neto	1.2%
Próxima actualización de resultados	25 Jul 2024

Actualizaciones de resultados anteriores recientes

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04

Recent updates

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Apr 22

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Apr 04

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Mar 05

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Feb 11

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Jun 12

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

May 27

Is Medicover (STO:MCOV B) Using Too Much Debt?

May 12

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Feb 16

Is Medicover (STO:MCOV B) Using Too Much Debt?

Jan 30

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Dec 30

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Dec 17

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Oct 30

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Oct 16

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Sep 09

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Jul 25

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Jul 12

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Jun 13

At kr179, Is It Time To Put Medicover AB (publ) (STO:MCOV B) On Your Watch List?

May 29

With EPS Growth And More, Medicover (STO:MCOV B) Is Interesting

Apr 20

Medicover (STO:MCOV B) Could Easily Take On More Debt

Apr 08

Medicover (STO:MCOV B) Is Doing The Right Things To Multiply Its Share Price

Mar 15

Is Now The Time To Look At Buying Medicover AB (publ) (STO:MCOV B)?

Feb 25

Desglose de ingresos y gastos

Cómo gana y gasta dinero Medicover. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

OM:MCOV B Ingresos, gastos y beneficios (EUR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	1,826	22	304
31 Dec 23	1,746	18	297
30 Sep 23	1,682	8	297
30 Jun 23	1,610	6	294
31 Mar 23	1,548	1	280
31 Dec 22	1,510	12	271
30 Sep 22	1,489	37	270
30 Jun 22	1,455	59	253
31 Mar 22	1,442	88	248
31 Dec 21	1,377	102	232
30 Sep 21	1,299	93	212
30 Jun 21	1,226	90	205
31 Mar 21	1,076	52	198
31 Dec 20	998	26	196
30 Sep 20	930	14	193
30 Jun 20	879	4	183
31 Mar 20	884	16	171
31 Dec 19	844	23	158
30 Sep 19	796	19	151
30 Jun 19	751	19	144
31 Mar 19	709	20	137
31 Dec 18	672	22	129
30 Sep 18	643	28	124
30 Jun 18	620	26	120
31 Mar 18	600	23	117
31 Dec 17	580	19	113
30 Sep 17	560	10	110
30 Jun 17	540	9	106
31 Mar 17	522	6	104
31 Dec 16	497	4	99
31 Dec 15	416	8	79
31 Dec 14	365	4	71

Ingresos de calidad: MCOV B tiene una única gran ganancia de €6.9M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2024.

Margen de beneficios creciente: Los actuales márgenes de beneficio (1%) de MCOV B son superiores a los del año pasado (0.8%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de MCOV B han crecido un 4.4% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de MCOV B en el último año (1492.9%) supera su media de 5 años (0.5% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de MCOV B en el último año (1492.9%) superó al de la industria Healthcare -8.4%.

Medicover Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released: EPS: €0.041 (vs €0.01 in 1Q 2023)

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

Full year 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings released: EPS: €0.037 (vs €0.01 in 2Q 2022)

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Full year 2022 earnings: Revenues in line with analyst expectations

Recent updates

General Legal Counsel recently sold kr1.2m worth of stock

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

First quarter 2024 earnings released: EPS: €0.041 (vs €0.01 in 1Q 2023)

Upcoming dividend of €0.12 per share

Investors Appear Satisfied With Medicover AB (publ)'s (STO:MCOV B) Prospects

Additional Considerations Required While Assessing Medicover's (STO:MCOV B) Strong Earnings

New minor risk - Earnings quality

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Dividend of €0.12 announced

Medicover AB (publ)'s (STO:MCOV B) Intrinsic Value Is Potentially 31% Above Its Share Price

Full year 2023 earnings: EPS exceeds analyst expectations

Now 24% undervalued

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Consensus EPS estimates increase by 27%

Returns On Capital At Medicover (STO:MCOV B) Paint A Concerning Picture

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Independent Chairman recently bought kr3.9m worth of stock

New minor risk - Earnings quality

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Independent Director recently bought kr303k worth of stock

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Medicover's (STO:MCOV B) Returns On Capital Not Reflecting Well On The Business

Medicover (STO:MCOV B) Has A Somewhat Strained Balance Sheet

Independent Director recently bought kr1.4m worth of stock

Independent Chairman recently bought kr6.3m worth of stock

Second quarter 2023 earnings released: EPS: €0.037 (vs €0.01 in 2Q 2022)

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Is There An Opportunity With Medicover AB (publ)'s (STO:MCOV B) 37% Undervaluation?

Chief Information Officer recently bought kr321k worth of stock

Medicover (STO:MCOV B) Will Want To Turn Around Its Return Trends

Is Medicover (STO:MCOV B) Using Too Much Debt?

Consensus EPS estimates fall by 10%

Now 21% undervalued after recent price drop

Upcoming dividend of €0.12 per share at 0.7% yield

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus EPS estimates fall by 72%

Now 23% undervalued

Full year 2022 earnings: Revenues in line with analyst expectations

Medicover AB (publ) Proposes Dividend for 2022

Returns On Capital At Medicover (STO:MCOV B) Have Hit The Brakes

Consensus EPS estimates fall by 26%

Is Medicover (STO:MCOV B) Using Too Much Debt?

Investor sentiment improved over the past week

Is Medicover AB (publ) (STO:MCOV B) Potentially Undervalued?

Estimating The Fair Value Of Medicover AB (publ) (STO:MCOV B)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues exceed analyst expectations

Medicover AB (publ) to Report Q2, 2023 Results on Jul 26, 2023

Medicover (STO:MCOV B) Might Have The Makings Of A Multi-Bagger

Medicover AB (publ) to Report Fiscal Year 2022 Results on Feb 17, 2023

Does Medicover (STO:MCOV B) Have A Healthy Balance Sheet?

Medicover AB (publ) (OM:MCOV B) acquired Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) completed the acquisition of Laurus Medical SRL.

Medicover AB (publ), Annual General Meeting, Apr 27, 2023

Should You Think About Buying Medicover AB (publ) (STO:MCOV B) Now?

Estimating The Intrinsic Value Of Medicover AB (publ) (STO:MCOV B)

Second quarter 2022 earnings: Revenues exceed analyst expectations

Medicover (STO:MCOV B) Has A Pretty Healthy Balance Sheet

Independent Chairman recently bought kr2.8m worth of stock

Medicover AB (publ) (OM:MCOV B) acquired Konzilijum.

Investors Met With Slowing Returns on Capital At Medicover (STO:MCOV B)

Medicover AB (publ) (OM:MCOV B) signed an agreement to acquire Übag Mvz Meindentist Gbr.

High number of new directors